Byrne G I

Top coauthors of Byrne G I

Carlin J M (12 papers)

Kalayoglu M V (10 papers)

Borden E C (10 papers)

Morrison R P (10 papers)

Ramsey K H (7 papers)

List of Byrne G I publications

2003

Ramsey K H, Sigar I M, Rana S V, Gupta J, Holland S M, et al. 2003. "Inducible nitric oxide synthase regulates production of isoprostanes in vivo during chlamydial genital infection in mice." Infection and immunity 71 (12) doi:

2001

Ramsey K H, Sigar I M, Rana S V, Gupta J, Holland S M, Byrne G I 2001. "Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals." Infection and immunity 69 (12) doi:10.1128/IAI.69.12.7374-7379.2001
Kalayoglu M V, Perkins B N, Byrne G I 2001. "Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells." Microbes and infection / Institut Pasteur 3 (12) doi:
Byrne G I, Ouellette S P, Wang Z, Rao J P, Lu L, et al. 2001. "Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells." Infection and immunity 69 (9) doi:
Ramsey K H, Miranpuri G S, Sigar I M, Ouellette S, Byrne G I 2001. "Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome." Infection and immunity 69 (8) doi:10.1128/IAI.69.8.5131-5137.2001

2000

Kalayoglu M V, Indrawati, Morrison R P, Morrison S G, Yuan Y, Byrne G I 2000. "Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions." The Journal of infectious diseases 181 Suppl 3 doi:10.1086/315619
LaVerda D, Albanese L N, Ruther P E, Morrison S G, Morrison R P, et al. 2000. "Seroreactivity to Chlamydia trachomatis Hsp10 correlates with severity of human genital tract disease." Infection and immunity 68 (1) doi:

1999

Byrne G I, Kalayoglu M V 1999. "Chlamydia pneumoniae and atherosclerosis: links to the disease process." American heart journal 138 (5 Pt 2) doi:
Kalayoglu M V, Hoerneman B, LaVerda D, Morrison S G, Morrison R P, Byrne G I 1999. "Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae." The Journal of infectious diseases 180 (3) doi:10.1086/314931
Ramsey K H, Cotter T W, Salyer R D, Miranpuri G S, Yanez M A, et al. 1999. "Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection." Infection and immunity 67 (6) doi:
Kalayoglu M V, Miranpuri G S, Golenbock D T, Byrne G I 1999. "Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae." Microbes and infection / Institut Pasteur 1 (6) doi:
Kane C D, Vena R M, Ouellette S P, Byrne G I 1999. "Intracellular tryptophan pool sizes may account for differences in gamma interferon-mediated inhibition and persistence of chlamydial growth in polarized and nonpolarized cells." Infection and immunity 67 (4) doi:
LaVerda D, Kalayoglu M V, Byrne G I 1999. "Chlamydial heat shock proteins and disease pathology: new paradigms for old problems?" Infectious diseases in obstetrics and gynecology 7 (1-2) doi:10.1155/S1064744999000137

1998

Kalayoglu M V, Byrne G I 1998. "A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide." Infection and immunity 66 (11) doi:
Kane C D, Byrne G I 1998. "Differential effects of gamma interferon on Chlamydia trachomatis growth in polarized and nonpolarized human epithelial cells in culture." Infection and immunity 66 (5) doi:
Kalayoglu M V, Byrne G I 1998. "Induction of macrophage foam cell formation by Chlamydia pneumoniae." The Journal of infectious diseases 177 (3) doi:
Ramsey K H, Miranpuri G S, Poulsen C E, Marthakis N B, Braune L M, Byrne G I 1998. "Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture." Infection and immunity 66 (2) doi:

1997

Cotter T W, Miranpuri G S, Ramsey K H, Poulsen C E, Byrne G I 1997. "Reactivation of chlamydial genital tract infection in mice." Infection and immunity 65 (6) doi:
Cotter T W, Ramsey K H, Miranpuri G S, Poulsen C E, Byrne G I 1997. "Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice." Infection and immunity 65 (6) doi:
LaVerda D, Byrne G I 1997. "Use of monoclonal antibodies to facilitate identification, cloning, and purification of Chlamydia trachomatis hsp10." Journal of clinical microbiology 35 (5) doi:

1996

Holland M J, Bailey R L, Conway D J, Culley F, Miranpuri G, et al. 1996. "T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring." Clinical and experimental immunology 105 (3) doi:

1995

Meyer K C, Arend R A, Kalayoglu M V, Rosenthal N S, Byrne G I, Brown R R 1995. "Tryptophan metabolism in chronic inflammatory lung disease." The Journal of laboratory and clinical medicine 126 (6) doi:
Hissong B D, Byrne G I, Padilla M L, Carlin J M 1995. "Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1." Cellular immunology 160 (2) doi:
Beatty W L, Morrison R P, Byrne G I 1995. "Reactivation of persistent Chlamydia trachomatis infection in cell culture." Infection and immunity 63 (1) doi:

1994

Beatty W L, Morrison R P, Byrne G I 1994. "Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis." Microbiological reviews 58 (4) doi:
Beatty W L, Morrison R P, Byrne G I 1994. "Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection." Infection and immunity 62 (9) doi:
Beatty W L, Belanger T A, Desai A A, Morrison R P, Byrne G I 1994. "Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence." Infection and immunity 62 (9) doi:
Malone D G, Dolan P W, Brown R R, Kalayoglu M V, Arend R A, et al. 1994. "Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells." The Journal of rheumatology 21 (6) doi:
Paguirigan A M, Byrne G I, Becht S, Carlin J M 1994. "Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures." Infection and immunity 62 (4) doi:
Beatty W L, Byrne G I, Morrison R P 1994. "Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease." Trends in microbiology 2 (3) doi:

1993

Byrne G I, Stephens R S, Ada G, Caldwell H D, Su H, et al. 1993. "Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings." The Journal of infectious diseases 168 (2) doi:
Thomas S M, Garrity L F, Brandt C R, Schobert C S, Feng G S, et al. 1993. "IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth." Journal of immunology (Baltimore, Md. : 1950) 150 (12) doi:
Beatty W L, Byrne G I, Morrison R P 1993. "Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro." Proceedings of the National Academy of Sciences of the United States of America 90 (9) doi:

1992

Meyer K C, Cornwell R, Carlin J M, Powers C, Irizarry A, et al. 1992. "Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide." American journal of respiratory cell and molecular biology 6 (6) doi:10.1165/ajrcmb/6.6.639

1991

Rapoza P A, Tahija S G, Carlin J P, Miller S L, Padilla M L, Byrne G I 1991. "Effect of interferon on a primary conjunctival epithelial cell model of trachoma." Investigative ophthalmology & visual science 32 (11) doi:

1990

Schiller J H, Horisberger M A, Bittner G, Carlin J M, Storer B, et al. 1990. "Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle." Journal of biological response modifiers 9 (4) doi:
Williams D M, Magee D M, Bonewald L F, Smith J G, Bleicker C A, et al. 1990. "A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis." Infection and immunity 58 (6) doi:

1989

Schmitz J L, Carlin J M, Borden E C, Byrne G I 1989. "Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages." Infection and immunity 57 (10) doi:
Carlin J M, Ozaki Y, Byrne G I, Brown R R, Borden E C 1989. "Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects." Experientia 45 (6) doi:
Carlin J M, Borden E C, Byrne G I 1989. "Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages." Journal of interferon research 9 (3) doi:
Guagliardi L E, Byrne G I, Paulnock D M 1989. "Differential modulation of lymphocyte proliferative responses and lymphokine secretion in mice during development of immunity to Chlamydia psittaci." Infection and immunity 57 (5) doi:
Williams D M, Bonewald L F, Roodman G D, Byrne G I, Magee D M, Schachter J 1989. "Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection." Infection and immunity 57 (5) doi:
Byrne G I, Carlin J M, Merkert T P, Arter D L 1989. "Long-term effects of gamma interferon on chlamydia-infected host cells: microbicidal activity follows microbistasis." Infection and immunity 57 (4) doi:
Carlin J M, Borden E C, Byrne G I 1989. "Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-beta Ser." Journal of interferon research 9 (2) doi:
Byrne G I, Schobert C S, Williams D M, Krueger D A 1989. "Characterization of gamma interferon-mediated cytotoxicity to chlamydia-infected fibroblasts." Infection and immunity 57 (3) doi:
Carlin J M, Borden E C, Sondel P M, Byrne G I 1989. "Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes." Journal of leukocyte biology 45 (1) doi:

1988

Williams D M, Byrne G I, Grubbs B, Marshal T J, Schachter J 1988. "Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice." Infection and immunity 56 (11) doi:
Byrne G I, Grubbs B, Marshall T J, Schachter J, Williams D M 1988. "Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection." Infection and immunity 56 (8) doi:
Huebner R E, Byrne G I 1988. "In vivo-activated mononuclear phagocytes and protective immunity to chlamydiae in mice." Infection and immunity 56 (6) doi:
Byrne G I, Guagliardi L E, Huebner R E, Paulnock D M 1988. "Immunomodulation and Chlamydia: immunosuppression and the protective immune response to C. psittaci in mice." Advances in experimental medicine and biology 239 doi:

1987

Mørland B, Byrne G I, Jones T C 1987. "The effect of intracellular Chlamydia psittaci on lysosomal enzyme activities in mouse peritoneal macrophages." Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology 95 (6) doi:
Borden E C, Rosenzweig I B, Byrne G I 1987. "Interferons: from virus inhibitor to modulator of amino acid and lipid metabolism." Journal of interferon research 7 (5) doi:
Carlin J M, Borden E C, Sondel P M, Byrne G I 1987. "Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures." Journal of immunology (Baltimore, Md. : 1950) 139 (7) doi:

1986

Byrne G I, Lehmann L K, Kirschbaum J G, Borden E C, Lee C M, Brown R R 1986. "Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity." Journal of interferon research 6 (4) doi:
Byrne G I, Lehmann L K, Landry G J 1986. "Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells." Infection and immunity 53 (2) doi:

1985

Byrne G I, Krueger D A 1985. "In vitro expression of factor-mediated cytotoxic activity generated during the immune response to Chlamydia in the mouse." Journal of immunology (Baltimore, Md. : 1950) 134 (6) doi:

1983

Byrne G I, Krueger D A 1983. "Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin." Infection and immunity 42 (3) doi:
Murray H W, Byrne G I, Rothermel C D, Cartelli D M 1983. "Lymphokine enhances oxygen-independent activity against intracellular pathogens." The Journal of experimental medicine 158 (1) doi:
Byrne G I, Faubion C L 1983. "Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation." Infection and immunity 40 (2) doi:
Byrne G I, Rothermel C D 1983. "Differential susceptibility of chlamydiae to exogenous fibroblast interferon." Infection and immunity 39 (2) doi:
Rothermel C D, Byrne G I, Havell E A 1983. "Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells)." Infection and immunity 39 (1) doi:

1982

Byrne G I, Faubion C L 1982. "Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages." Journal of immunology (Baltimore, Md. : 1950) 128 (1) doi:

1979

Gregory W W, Byrne G I, Gardner M, Moulder J W 1979. "Cytochalasin B does not inhibit ingestion of Chlamydia psittaci by mouse fibroblasts (L cells) and mouse peritoneal macrophages." Infection and immunity 25 (1) doi:
Gregory W W, Gardner M, Byrne G I, Moulder J W 1979. "Arrays of hemispheric surface projections on Chlamydia psittaci and Chlamydia trachomatis observed by scanning electron microscopy." Journal of bacteriology 138 (1) doi:

1978

Byrne G I, Moulder J W 1978. "Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells." Infection and immunity 19 (2) doi:
Byrne G I 1978. "Kinetics of phagocytosis of Chlamydia psittaci by mouse fibroblasts (L cells): separation of the attachment and ingestion stages." Infection and immunity 19 (2) doi:

1976

Byrne G I 1976. "Requirements for ingestion of Chlamydia psittaci by mouse fibroblasts (L cells)." Infection and immunity 14 (3) doi:
Moulder J W, Hatch T P, Byrne G I, Kellogg K R 1976. "Immediate toxicity of high multiplicities of Chlamydia psittaci for mouse fibroblasts (L cells)." Infection and immunity 14 (1) doi: